Loading viewer...
presentation
Format: PDF presentation
UPM's Q2 2023 presentation highlights significant market downturns, financial results, and ongoing transformation efforts amidst challenging conditions.
investor_presentation
presentation
Global Blood Therapeutics
presentation
Cabaletta Bio
presentation
Applied DNA Sciences
presentation
Sanofi